Dr. Rudin is the Sylvia Hassenfeld Professor and Chief of Thoracic Oncology at Memorial Sloan Kettering Cancer Center in New York, where he also co-directs the Druckenmiller Center for Lung Cancer Research. Charlie oversees a broad and integrated program of preclinical and clinical research in lung cancer, spanning from basic discovery science, preclinical modeling and novel therapeutic target identification, first-in-human phase I clinical testing, through leadership of definitive national and international phase 3 studies. He also chairs the NCI Small Cell Lung Cancer Research Consortium, a national network of investigators studying SCLC oncogenesis, mouse and human preclinical modeling, genomic and epigenetic drivers, and therapeutic vulnerabilities.
About
